Fabrication and characterization of nanofibrous tricuspid valve scaffold based on polyurethane for heart valve tissue engineering
Authors
Abstract:
Objective(s): Tissue engineering represents a new approach to solve the current complications of the heart valve replacements by offering viable valve prosthesis with growth and remodeling capability. In this project, electrospinning and dip coating techniques were used to fabricate heart valve constructs from medical grade polyurethane (PU). Methods: First, a mold of tricuspid valve was dip coated in a PU solution, except for its valvular parts. Then, PU nanofibers were electrospun on the dip coated mold to form the valves. The morphology and diameter of nanofibers were investigated by SEM and contact angle measurements were done to evaluate the wettability of scaffolds. Thereafter, a tensile tester machine was used to assess mechanical properties of nanofibrous scaffolds. Then, the HUVEC cell line was cultured on the surface of scaffolds. Results: The SEM images showed the proper nanofibrous structure of the prepared scaffolds. Also, the obtained structure demonstrated appropriate tensile properties. Based on direct and indirect MTT, DAPI staining and SEM results, nanofibers were biocompatible and cells attached to the surface of the scaffolds, properly. Conclusions: This study demonstrated polyurethane-based nanofibrous scaffolds for engineering artificial heart valve. The presented scaffold provides temporary support for cells prior to generation of extracellular matrix (ECM).
similar resources
Heart valve tissue engineering.
Tissue-engineered heart valves have been proposed by physicians and scientists alike to be the ultimate solution for treating valvular heart disease. Rather than replacing a diseased or defective native valve with a mechanical or animal tissue-derived artificial valve, a tissue-engineered valve would be a living organ, able to respond to growth and physiological forces in the same way that the ...
full textfabrication and characterization of spongy denuded amniotic membrane based scaffold for tissue engineering
objective: as a biological tissue material, amniotic membrane (am) has low immunogenicity and to date has been widely adopted in clinical practice. however, some features such as low biomechanical consistency and rapid biodegradation is limited the application of am. therefore, in this study, we fabricated a novel three-dimensional (3d) spongy scaffold made of the extracellular matrix (ecm) of ...
full textAutologous heart valve tissue engineering
• A submitted manuscript is the author's version of the article upon submission and before peer-review. There can be important differences between the submitted version and the official published version of record. People interested in the research are advised to contact the author for the final version of the publication, or visit the DOI to the publisher's website. • The final author version ...
full textNanofibrous scaffold in tissue engineering
Dear Friends, Nanofibrous scaffolds have been a major revolution in the field of tissue engineering which may improve the health and quality of life by enhancing tissue function. These are the artificial extracellular matrices which offer natural surroundings for tissue formation. Owing to their high surface to volume ratio, nanofibrous scaffolds increase cell adhesion, proliferation, and diffe...
full textKnitting for heart valve tissue engineering
Knitting is a versatile technology which offers a large portfolio of products and solutions of interest in heart valve (HV) tissue engineering (TE). One of the main advantages of knitting is its ability to construct complex shapes and structures by precisely assembling the yarns in the desired position. With this in mind, knitting could be employed to construct a HV scaffold that closely resemb...
full textElectrospun Scaffolds for Heart Valve Tissue Engineering
INTRODUCTION Heart valve replacements are required for a number of heart diseases and replacements, as well as for both pediatric and adult populations. It is estimated that 2.5% of the population has valvular heart disease [1], and annually, over 250,000 people worldwide receive heart valve replacements [1]. Tissue engineering (TE) strategies hold the most promise for permanently restoring the...
full textMy Resources
Journal title
volume 2 issue 2
pages 131- 141
publication date 2017-04-01
By following a journal you will be notified via email when a new issue of this journal is published.
Keywords
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023